Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05604326 · ClinicalTrials.gov registry record · NA
Evaluating the Efficacy of Pathways Parent-Mediated Early Autism Intervention on Social Attention and Language
A NA study, sponsored by The University of Texas at Dallas.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
NCT05604326 is a NA study that has completed, run by The University of Texas at Dallas. The registered enrollment target is 58 participants.
The verdict
NCT05604326, a NA study, has completed, sponsored by The University of Texas at Dallas.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare the efficacy of Pathways parent-mediated early autism intervention (Pathways) and a parent education intervention (PEI) delivered to culturally and linguistically diverse families with children 12-42 months of age suspected of or diagnosed with autism. Question 1: Is Pathways more effective than a PEI at (a) fostering the development of social orienting, joint attention, and social communication and language in children with a research diagnosis of autism and (b) relieving their parents' stress? Question 2: Is the magnitude of the relationship between early and later developing attention greater in children whose parents receive Pathways compared to children whose parents receive PEI? Question 3: Is the magnitude of the relationship between joint attention and social communication and language greater in children whose parents receive Pathways compared to children whose parents receive PEI? Participants will be randomized into 24 weeks of Pathways or PEI. Participants will receive a battery of assessments to evaluate the child's cognitive, social attention, social communication, language, and adaptive functioning, and parental stress at four different time points spaced every 12 weeks from baseline to three-month follow-up.
Interventions
- BEHAVIORAL Pathways Intervention
- BEHAVIORAL Parent Education Intervention (PEI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2022-10-27 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05604326
The ClinicalTrials.gov registry entry for NCT05604326 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas at Dallas, which has 50 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pathways Intervention is the first listed.
NCT05604326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05604326 about?
NCT05604326 is a clinical study titled "Evaluating the Efficacy of Pathways Parent-Mediated Early Autism Intervention on Social Attention and Language". The goal of this clinical trial is to compare the efficacy of Pathways parent-mediated early autism intervention (Pathways) and a parent education intervention (PEI) delivered to culturally and linguistically diverse families with children 12-42 months of age suspected of or diagnosed with autism. ...
What is the current status of trial NCT05604326?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2022-10-27. Estimated completion is 2025-02-01.
What interventions are being tested in trial NCT05604326?
The interventions under investigation include: Pathways Intervention (BEHAVIORAL), Parent Education Intervention (PEI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05604326?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.